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Abstract A growing number of studies have demonstrated
the importance of ATPe-signalling via P2 receptors as an
important component of the inflammatory response to
infection. More recent studies have shown that ATPe can
also have a direct effect on infection by intracellular
pathogens, by modulating membrane trafficking in cells
that contain vacuoles that harbour intracellular pathogens,
such as mycobacteria and chlamydiae. A conserved
mechanism appears to be involved in controlling infection
by both of these pathogens, as a role for phospholipase D in
inducing fusion between lysosomes and the vacuoles has
been demonstrated. Other P2-dependent mechanisms are
most likely operative in the cases of pathogens, such as
Leishmania, which survive in an acidic phagolysosomal-
like compartment. ATPe may function as a “danger signal”
that alerts the immune system to the presence of intracel-
lular pathogens that damage the host cell, while different
intracellular pathogens have evolved enzymes or other
mechanisms to inhibit ATPe-mediated signalling, which











ROI Reactive oxygen intermediates
RNI Reactive nitrogen intermediates
TNF-! Tumour necrosis factor-!
Introduction
Intracellular pathogens invade, survive and replicate in
mammalian cells, modulating host-cell membrane traffick-
ing and cytoskeletal dynamics in order to establish
persistent infection in the mammalian host [1–3]. Macro-
phages are a frequent target of microbial infections, and
they respond to microbial invasion by producing factors
such as reactive nitrogen and oxygen intermediates (RNIs
and ROIs) that have strong microbicidal activity [4]. But
many pathogens have evolved different strategies for
avoiding destruction by the macrophage. Some intracellular
pathogens, such as Mycobacteria, inhabit a compartment
whose endocytic maturation is delayed, while Chlamydiae
survive within a membrane-bound vacuole that avoids
fusion with lysosomes and maintains a neutral pH [5, 6].
Unlike Mycobacteria and Chlamydia, the protozoan para-
site Leishmania thrives in a parasitophorous vacuole that
has an acidic pH and high hydrolytic activity, and
Trypanosoma cruzi actively induces its uptake into lyso-
some-like host-cell vacuoles, from which, the parasite
rapidly escapes into the cytosol [7–10].
Purinergic Signalling (2007) 3:83–90
DOI 10.1007/s11302-006-9039-6
R. Coutinho-Silva (*):C. Monteiro da Cruz:P. M. Persechini
Programa de Imunobiologia, Instituto de Biofísica Carlos
Chagas Filho, Universidade Federal do Rio de Janeiro (UFRJ),
Bloco G do CCS, Cidade Universitária,
Ilha do Fundão, Rio de Janeiro 21941-590, Brazil
e-mail: rcsilva@biof.ufrj.br
C. Monteiro da Cruz:D. M. Ojcius
School of Natural Sciences,
University of California, Merced, CA, USAAt the end of their infection cycle, each of these
intracellular parasites is released from the host cell,
triggering macrophage death and inducing local inflam-
mation, accompanied by the possible release of ATP, as
shown for macrophages infected with Mycobacterium
tuberculosis [11]. As extracellular ATP (ATPe) can be used
by neighbouring macrophages as ammunition to inhibit
infection (described below), many intracellular pathogens—
such as Mycobacterium bovis BCG, Vibrio cholerae, M.
tuberculosis, T. cruzi and Leishmania—also secrete or
express on their outer surface enzymes that degrade or
synthesise nucleotides [12–15]; and microbial enzymes that
consume or produce ATP are considered as virulence
factors for M. tuberculosis, Leishmania amazonensis and
T. cruzi [14, 16–18].
Macrophages activate microbicidal pathways and con-
tribute to inflammation after the ligation of purinergic P2
receptors by ATPe. This review will, therefore, describe
some of the P2-dependent mechanisms used by macro-
phages to eliminate infection by intracellular bacteria and
protozoan parasites, and, whenever possible, will correlate
these findings with host susceptibility and resistance to
infection.
Effect of ATPe on macrophage infection
by M. tuberculosis
The first evidence for an involvement of ATPe in the
control of intracellular infections came from the laboratory
of Kaplan, who demonstrated in 1994, that ATPe-mediated
apoptosis in Mycobacterium tuberculosis-infected macro-
phages is associated with the inhibition of mycobacterial
infection [19]. This early study also showed that ATPe-
induced macrophage apoptosis, but not H2O2-induced
necrosis, is associated with the killing of the intracellular
mycobacteria. These findings were confirmed by Lammas
et al., who proposed that the ATPe-induced elimination of
BCG-infected human macrophages are mediated by the
purinergic receptor, P2X7, through a mechanism indepen-
dent of both RNIs and ROIs [20]. In comparison with other
ligands that can trigger the lysis of macrophages, including
complement-mediated cytolysis, Fas ligation and CD69
activation, only ATPe treatment could stimulate the death of
both host macrophages and intracellular mycobacteria.
Subsequently, several laboratories confirmed that the
P2X7 receptor plays a role in limiting infection in murine
and bovine macrophages infected with mycobacteria, and in
human macrophages infected with BCG bacillus and
virulent strains of M. tuberculosis [11, 21–23].
In addition to the P2X7 receptor, other P2 receptor
subtypes, possibly P2Y, are apparently involved in ATPe-
mediated bactericidal activity in macrophages [11, 21, 23].
Experiments using macrophages derived from P2X7-defi-
cient mice revealed that ATPe stimulates the production of
reactive species such as RNIs equally well in both wildtype
and P2X7-deficient macrophages [11]. Moreover, it was
found that ATPe induces bactericidal effects in the macro-
phages better than BzATP (the most potent known agonist
for the P2X7 receptor), suggesting that P2X7 receptors are
necessary, but not sufficient, for maximal ATPe-dependent
killing of intracellular M. tuberculosis by human and
bovine macrophages [21, 22]. Lammas et al. have further
observed that the ATPe activity is potentiated by extracel-
lular Zn
2+ [20]. This effect was initially ascribed to the
P2X7 receptor, but now, P2X7 activity is known to be
blocked by extracellular Zn
2+, while the activity of another
purinergic receptor, P2X4, is potentiated by Zn
2+ [24].
Since macrophages express functional P2X4 receptors [25]
and inflammatory mediators can upregulate this receptor on
macrophages [26], it is likely that both P2X7 and P2X4 are
involved in the ATPe-induced killing of M. tuberculosis in
macrophages.
More recent reports have also confirmed the predomi-
nant role of the P2X7 receptor in mycobacterial clearance,
extending these results to show that loss-of-function poly-
morphisms in human P2X7 receptors lead not only to
reduced ATPe-induced apoptosis, but also to impaired
ATPe-induced killing of intracellular mycobacteria (BCG)
by macrophages [27–29]. Nonetheless, more experiments
will be required to elucidate the role that P2X7, possibly in
conjunction with other P2 receptors, may play in the killing
of intracellular mycobacteria in vivo, since P2X7-deficient
mice control lung infection as well as wildtype mice after
low-dose aerosol infection with virulent M. tuberculosis
[30].
Cellular mechanisms of ATPe-induced
mycobacterial killing
ATPe ligation of P2X7 on macrophages results in a variety
of different cellular effects, including the activation of
phospholipase D (PLD), maturation and release of inter-
leukin-1β (IL-1β), generation of macrophage polykarions,
modulation of lipopolysaccharide (LPS) induced macro-
phage activation through modulation of iNOS expression
and NO production, and the induction of macrophage death
by necrosis and/or apoptosis [31–40]. The original findings
from the Kaplan laboratory suggested that the apoptosis of
macrophages is necessary for ATPe-mediated killing of
intracellular bacteria [19], but it was later established that
the ATPe-induced killing of mycobacteria in human and
mice macrophages can occur without macrophage death,
through a pathway requiring PLD activation, the acidifica-
tion of phagosomes and phagosome–lysosome fusion [21]
84 Purinergic Signalling (2007) 3:83–90(Fig. 1)[ 23, 41]. A more recent study showed that, when
combined, two loss-of-function polymorphisms in human
P2X7 receptors impair ATPe-mediated apoptosis, despite
the normal killing of BCG bacillus [28], reinforcing the
view that the apoptosis of macrophages is not necessary for
the elimination of mycobacteria.
In fact, it was recently shown [42] that cyclosporine A,
an inhibitor of the mitochondrial permeability transition,
increases the survival of human monocyte-derived macro-
phages infected with M. tuberculosis,r e s t o r e sP 2 X 7
function and enhances antimycobacterial activity. Con-
versely, M. tuberculosis has developed mechanisms to
evade P2X7-triggered mechanisms, since it can secrete a
nucleoside diphosphate kinase that produces ATP and kills
macrophages through a P2X7-dependent mechanism [14].
New experiments are needed to clarify the role played by
ATPe in killing intracellular pathogens and inducing host-
cell death.
Inhibition of chlamydial infection in macrophages
The Chlamydia species are obligate intracellular bacteria
that infect mainly epithelial mucosa, where they survive
within intracellular vacuoles that avoid fusion with host-cell
lysosomes [6, 43]. Different strains of C. trachomatis are
responsible for the infection of genital and ocular tissue in
humans [44–48]. C. pneumoniae is a common cause of
community-acquiredpneumoniainhumansandisassociated
with an increased risk for atherosclerosis [44, 49]. Both C.
trachomatis and C. pneumoniae can invade epithelial cells
and macrophages in vitro and in vivo [49, 50].
It was recently shown that ATPe inhibits the infection of
macrophages by the murine species of C. trachomatis, C.
muridarum, through a mechanism that required PLD
activation and fusion between lysosomes and the Chlamyd-
ia vacuoles [51]. The effect of ATPe was dependent on the
presence of the P2X7 receptor, since there was no PLD
activation nor killing of chlamydiae in infected macro-
phages that had been isolated from P2X7-deficient mice.
Although P2X7 ligation also led to macrophage death, the
inhibition of PLD prevented chlamydial killing but had no
effect on macrophage death, suggesting that PLD activation
was directly responsible for the inhibition of chlamydial
infection (Table 1). Moreover, fusion between lysosomes
and chlamydial vacuoles preceded macrophage death,
further strengthening the conclusion that the killing of
chlamydiae is independent of host-cell death [51].
Fig. 1 ATP released from infected cells undergoing necrosis or sites of
inflammation can bind to the P2X7 receptor on neighbouring macro-
phages and other cells. Ligation of the P2X7 receptor initiates
signalling through several pathways, which result in the activation of
caspase-1, activation of phospholipase D (PLD) and, ultimately, cell
death. Caspase-1 activation stimulates the inflammatory response by
the cleavage of pro-IL-1β and secretion of the mature cytokine. PLD
activation modifies membrane trafficking in the cell, which can induce
fusion between lysosomes and vacuoles, harbouring intracellular
pathogens such as mycobacteria and chlamydiae. The death of
macrophages is partly necrotic, which may amplify inflammation even
further, through the ligation of P2X7 receptors on other cells. Some
extracellular ATP may also bind to other P2 receptors, which may
inhibit infection by activating as-yet-uncharacterised pathways
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ways is deleterious for Chlamydia, both directly and
through the demise of the macrophage, the intracellular
pathogen has also evolved a mechanism for protecting its
host cell. Thus, the infection of macrophages with a related
species, C. psittaci (also known as C. caviae), inhibits
partially ATPe-mediated macrophage death [52]. While the
molecular basis for host-cell protection remains to be
investigated, chlamydial infection decreases partially the
ability of ATPe to induce plasma–membrane permeabilisa-
tion and calcium fluxes [52]. Chlamydiae, therefore,
resemble other pathogenic bacteria and protozoan parasites
that attempt to protect themselves and the host cell by
degrading nucleotides or hydrolysing ATP.
Effects of ATPe on leishmaniasis
Leishmaniasis is used to describe several diseases caused
by the obligate intracellular protozoan parasite Leishmania,
which infects mainly macrophages [53]. The diseases range
from self-healing cutaneous lesions to visceral and poten-
tially fatal disseminating infection. Leishmania infections
are found in 80 countries, with a prevalence of 12 million
human cases. The development of different clinical forms is
associated with both the immunological status of the host
and the parasite species [53]. The expression of the P2X7
receptor has recently been examined during Leishmania
infection, revealing upregulation of the receptor during both
in vivo and in vitro infection with L. amazonensis [54].
These changes were correlated with functional responses,
as reflected by an increase in ATPe-mediated plasma–
membrane permeabilisation and host-cell apoptosis ([54]
and Chaves et al. (manuscript in preparation)) (Table 1).
The increase in ATPe-induced membrane permeabilisation
was also observed in spleen macrophages isolated from mice
infected with L. donovani, suggesting that this may be a
general phenomenon relevant for all Leishmania infections.
It has been proposed that intracellular infection by
Leishmania donovani inhibits macrophage apoptosis in-
duced by growth factor deprivation [55]. In contrast, there
is an increase in the ATPe-mediated apoptosis of macro-
phages infected with Leishmania (our unpublished data),
consistent with the increases in ATPe-mediated membrane
permeabilisation. Thus, despite the production of ecto-
ATPases by Leishmania [16], this strategy is not sufficient
to protect the host cell against the infection-dependent
upregulation in P2X7 expression.
We have observed that the presence of ATPe during L.
amazonensis infection does not interfere with Leishmania
invasion, but the ATPe treatment of macrophages that are
already infected with L. amazonensi leads to a decrease in
Leishmania survival (our unpublished observations). In
addition, we observed that ATPe has no effect on the
Table 1 Effect of extracellular ATP on intracellular pathogens




Human macrophages BCG –Mycobacterial clearance Not determined [19]
Human macrophages BCG –Mycobacterial clearance P2X7, P2Y [20], [23]
BCG—M. tuberculosis
H37Ra
–Acidification of mycobacteria-containing phagosomes
–Inhibition of P2X7-associated permeabilsation
P2X7 [42]
Mouse macrophage BCG Production of NO and ROI P2Y(?) [11]
Human macrophages M. tuberculosis (H37Rv,
Erdman and CSU#93)
Mycobacterial clearance; PLD activation P2X7+P2(?) [21]
Mouse macrophages
and J774 cell line
BCG Mycobacterial clearance, PLD activation, phagosome–
lysosome fusion
P2X7 [41]
Bovine macrophages BCG Mycobacterial clearance, increase P2X7 mRNA P2X7 [22]
J774 macrophage C. caviae – Chlamydial clearance– Inhibition of P2X7-mediated
apoptosis
P2X7 [52]
Mouse macrophages C. trachomatis Chlamydial clearance, PLD activation, phagosome–
lysosome fusion
P2X7 [51]
Mouse thymocytes T. cruzi Modulation of thymocyte death P2X7 (?) [64]
Mouse macrophages T. cruzi Inhibition of P2X7-mediated permeabilisation P2X7 [65]
Mouse macrophages L. amazonensis; L.
donovani
Increase of P2X7-mediated permeabilisation P2X7 [54]
PLD=phospholipase D; ROI=reactive oxygen intermediates
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some nucleotides, such as UTP, stimulate the proliferation
of promastigotes. It is also worthwhile noting that the more
infective forms of L. amazonensis express more magne-
sium-dependent ecto-ATPase on their membranes than less
virulent Leishmania, leading to the proposal that the ecto-
ATPase should be viewed as a virulence factor of the
parasite [16].
The cellular pathway allowing ATPe to decrease Leish-
mania infection remains to be determined, but must be
different from the PLD activation observed during Chla-
mydia and Mycobacterium infection [41, 51], since both
Chlamydia and Mycobacterium inhibit phagolysosome
formation and acidification [4, 6, 8], while Leishmania
survives well in acidic phagolysosomes [56]. Interestingly,
Leishmania lipophosphoglycans, which promote parasite
survival, act by perturbing MAPKinase signalling in
macrophages to inhibit macrophage IL-1β [57]. This might
be relevant for the involvement of P2 receptors in the
escape mechanisms used by Leishmania, since several P2
receptors are connected to MAPKinase pathways [58].
The involvement of ATPe in Chagas’ disease
Chagas’ disease is caused by the facultative intracellular
protozoan pathogen, T. cruzi. The disease is a chronic
inflammatory condition characterised by cardiomyopathy
and digestive disorders [59, 60]. T. cruzi infection affects
over 17 million people in endemic areas of Latin America,
leading to 45 thousand deaths per year [61]. The involve-
ment of ATPe signalling was recently examined during the
acute phase of T. cruzi infection. Thymus atrophy occurs
during the acute phase of infection but the thymus recovers
weight and cellularity during the chronic phase [62]. These
alterations do not appear to be associated with stress or
glucocorticoid release [63]. It has recently been observed
that thymocytes are sensitive to ATPe-induced membrane
permeabilisation and host-cell death only during the
atrophy phase of infection, with CD4
+/CD8
+ double-
positive thymocytes being the most sensitive subpopulation
of thymocytes [64] (Table 1). Since the phenomenon of
ATP-induced permeabilisation can be blocked by the P2X7
inhibitors, oxidised ATP and Mg
2+, and the P2X7 agonist,
BzATP, was more potent than ATP, we proposed that the
increased sensitivity to ATPe may be responsible, at least in
part, for the thymocyte clearance and thymic atrophy
observed during the acute phase of Chagas’s disease [64].
It is, therefore, reasonable to suppose that ATPe plays an
important role in the T. cruzi infection cycle. In this context,
it is worth noting that the ecto-ATPases produced by these
parasites have been associated with strain virulence [17].
P2X7 receptors and inflammation
The stimulation of P2X7 by ATPe leads to caspase-1
activation, cleavage of pro-IL-1β and the secretion of
mature IL-1β [66] (Fig. 1). The P2X7 receptor is also
upregulated in macrophages by inflammatory cytokines,
such as interferon-+ (IFN-+) and tumour necrosis factor-!
(TNF-!), and lipopolysaccharide (LPS). LPS, a surface
component of most Gram-negative bacteria, and IFN-+ act
synergistically to upregulate P2X7 receptor function and
P2X7 mRNA in the human monocyte cell line, THP-1, and
human macrophages [34, 37]. In fact, P2X7 receptors
contain several motifs that are homologous to motifs from
other receptors known to be involved in protein–protein
interactions and LPS binding [67]. The upregulation of
P2X7 expression in monocytes by TNF-!, LPS and IFN-+ is
consistent with the ability of these cytokines to act as
inflammatory mediators, and these effects are markedly
attenuated by coincubation with prostaglandin E2 (PGE2)
or the membrane-permeable cAMP analogue, dibutyril
cAMP [68]. It is tempting to speculate that the temporal
sequence of macrophage exposure to pro-inflammatory
activators and anti-inflammatory stimuli (such as PGE2)
might regulate not only receptor expression, but also
downstream signalling by the P2X7 receptors.
It is known that macrophages express adenosine recep-
tors, which are expressed during the differentiation of mono-
cytes to macrophages and may influence phagocytosis [69].
Moreover, the treatment of macrophages with IFN-+
upregulates expression of the adenosine receptor, A2B, and
the activation of A2B receptors is involved with the deac-
tivation of macrophages, possibly through an increase of
cAMP [70]. Therefore, the extracellular nucleotides may be
involved with activation and a feedback mechanism for
macrophage deactivation, depending on the timing and type
of nucleotide released during infection. In this context,
\studies with P2X7-deficient mice have reinforced the view
that P2X7 receptors are involved in inflammation. Thus,
disruption of the P2X7 receptor gene is associated with less
severe disease in an arthritis model [71] and studies of
chronicinflammationandneuropathicpain[72].Theseresults
led to the hypothesis that the P2X7 receptor, through the
regulation of IL-1β production and secretion, plays a
common, early role in the development of pain of
neuropathic and inflammatory origin [71, 72]. Additionally,
a recent study demonstrates that the inhibition of the P2X7
receptor attenuates fever and cytokine responses induced by
LPS in rats [73]. Finally, the P2X7 receptor is present and its
expression is modulated by inflammation in sites of chronic
inflammation [74].
All of these findings reinforce the conclusion that
P2X7-dependent signalling plays a significant role in host
Purinergic Signalling (2007) 3:83–90 87responses during various types of inflammatory disease.
However, the involvement of P2X7 during disease is
complicated by the presence of other P2 receptors, which
may also contribute to either pro- or anti-inflammatory
immune responses. Moreover, ATP can negatively regulate
Toll-like receptor signalling, suppress LPS-induced MCP-1
and TNF-!, and augments IL-10 production in human
monocytes [75]. Many infectious agents that survive in
these immune effector cells may have evolved complex
nucleotide-based strategies to evade the immune system.
Dissection of these strategies may lead us to a better
understanding of the role of nucleotide signalling in the
immune response and to the development of new
approaches to combat infectious diseases.
Concluding remarks
As large concentrations of ATP are present outside of the cell
only when the cell is damaged or is part of an inflamed tissue
(Fig. 1), it has been proposed that ATPe may function as a
generic “danger signal,” which could alert the immune
system to the presence of any type of intracellular pathogen
that induces host-cell death [76–78]. Different intracellular
pathogens, such as bacteria and protozoan parasites,
express ecto-ATPases or other mechanisms to either inhibit
or enhance ATPe-mediated death of their host cell,
suggesting that ATPe may have been used by the host as
an ancient danger signal, to which, intracellular pathogens
have been exposed since the early evolution of the immune
system. In this context, the ability of some intracellular
pathogens to inhibit the ATPe-dependent response mediated
by P2 receptors could be an example of adaptation of the
pathogenic invaders to the immune response, and may help
to explain why the most virulent pathogens express high
ecto-ATPase levels on their surface [14–17]. Given the
availability of animals that are deficient in P2X7 and other
P2 receptors, further research in the future will, thus, need
to address the relevance of P2-dependent immune mecha-
nisms in controlling infections in whole organisms.
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